Manolo Carta, Ph.D.
|2010-||Biomedical Sciences||Cagliari University|
Mean distance: 15.36 (cluster 11)
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Scheggi S, Rossi F, Corsi S, et al. (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease|
|Meloni M, Puligheddu M, Sanna F, et al. (2020) Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869|
|Carta G, Murru E, Vargiu R, et al. (2020) Essential fatty acids deficient diet modulates N-Acylethanolamide profile in rat's tissues. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 153: 102053|
|Nuzzo T, Punzo D, Devoto P, et al. (2019) The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients. Scientific Reports. 9: 8898|
|Fanni S, Scheggi S, Rossi F, et al. (2018) 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130|
|Carta M, Björklund A. (2018) The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective. Journal of Neural Transmission (Vienna, Austria : 1996)|
|Tronci E, Napolitano F, Muñoz A, et al. (2017) BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology|
|D Ko WK, Li Q, Yun Cheng L, et al. (2017) A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease. European Journal of Pharmacology|
|Frau R, Savoia P, Fanni S, et al. (2017) The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology|
|Pinna A, Ko WK, Costa G, et al. (2016) Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society|